TY - JOUR
T1 - Chyle Leak Following Radical En Bloc Esophagectomy with Two-Field Nodal Dissection
T2 - Predisposing Factors, Management, and Outcomes
AU - Milito, Pamela
AU - Chmelo, Jakub
AU - Dunn, Lorna
AU - Kamarajah, Sivesh K.
AU - Madhavan, Anantha
AU - Wahed, Shajahan
AU - Immanuel, Arul
AU - Griffin, S. Michael
AU - Phillips, Alexander W.
N1 - Publisher Copyright:
© 2020, The Author(s).
PY - 2021/7
Y1 - 2021/7
N2 - Background: Chyle leak is an uncommon complication following esophagectomy, accounting for significant morbidity and mortality; however, the optimal treatment for the chylothorax is still controversial. Objective: The aim of this study was to evaluate the incidence, management, and outcomes of chyle leaks within a specialist esophagogastric cancer center. Methods: Consecutive patients undergoing esophagectomy for esophageal cancers (adenocarcinoma or squamous cell carcinoma) between 1997 and 2017 at the Northern Oesophagogastric Unit were included from a contemporaneously maintained database. Primary outcome was overall survival, while secondary outcomes were overall complications, anastomotic leaks, and pulmonary complications. Results: During the study period, 992 patients underwent esophagectomy for esophageal cancers, and 5% (n = 50) of them developed chyle leaks. There was no significant difference in survival in patients who developed a chyle leak compared with those who did not (median: 40 vs. 45 months; p = 0.60). Patients developing chyle leaks had a significantly longer length of stay in critical care (median: 4 vs. 2 days; p = 0.002), but no difference in total length of hospital stay. Conclusion: Chyle leak remains a complication following esophagectomy, with limited understanding on its pathophysiology in postoperative recovery. However, these data indicate chyle leak does not have a long-term impact on patients and does not affect long-term survival.
AB - Background: Chyle leak is an uncommon complication following esophagectomy, accounting for significant morbidity and mortality; however, the optimal treatment for the chylothorax is still controversial. Objective: The aim of this study was to evaluate the incidence, management, and outcomes of chyle leaks within a specialist esophagogastric cancer center. Methods: Consecutive patients undergoing esophagectomy for esophageal cancers (adenocarcinoma or squamous cell carcinoma) between 1997 and 2017 at the Northern Oesophagogastric Unit were included from a contemporaneously maintained database. Primary outcome was overall survival, while secondary outcomes were overall complications, anastomotic leaks, and pulmonary complications. Results: During the study period, 992 patients underwent esophagectomy for esophageal cancers, and 5% (n = 50) of them developed chyle leaks. There was no significant difference in survival in patients who developed a chyle leak compared with those who did not (median: 40 vs. 45 months; p = 0.60). Patients developing chyle leaks had a significantly longer length of stay in critical care (median: 4 vs. 2 days; p = 0.002), but no difference in total length of hospital stay. Conclusion: Chyle leak remains a complication following esophagectomy, with limited understanding on its pathophysiology in postoperative recovery. However, these data indicate chyle leak does not have a long-term impact on patients and does not affect long-term survival.
UR - http://www.scopus.com/inward/record.url?scp=85096406082&partnerID=8YFLogxK
U2 - 10.1245/s10434-020-09399-1
DO - 10.1245/s10434-020-09399-1
M3 - Article
C2 - 33263829
AN - SCOPUS:85096406082
SN - 1068-9265
VL - 28
SP - 3963
EP - 3972
JO - Annals of Surgical Oncology
JF - Annals of Surgical Oncology
IS - 7
ER -